AI-generated summary
The authors systematically reviewed 43 articles on ocular complaints and eye examinations in light therapy studies. They report that ocular complaints occurred in roughly 0% to 45% of participants, with no clear relationship to dose and no evidence of ocular damage apart from one case report of maculopathy in a patient taking clomipramine. They conclude light therapy appears safe for the eyes in physically healthy, unmedicated people, while noting that persons with preexisting eye conditions warrant further study.
- Studies included
- 43
- Who or what was studied
- Participants in studies involving light therapy, including physically healthy, unmedicated persons and a single case report of a person taking clomipramine
- Limits stated in the abstract
- The abstract notes that the ocular safety of light therapy in persons with preexisting ocular abnormalities or increased photosensitivity requires further study, and dose relationships were assessed only from individual studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Case report, Depression, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.